Correction: Identification of Potential Pathway Mediation Targets in Toll-like Receptor Signaling

PLoS Computational Biology (Impact Factor: 4.62). 11/2009; 5(11). DOI: 10.1371/annotation/5cc0d918-83b8-44e4-9778-b96a249d4099
Source: PubMed


[This corrects the article on p. e1000292 in vol. 5, PMID: 19229310.].

Download full-text


Available from: Ines Thiele, Jan 06, 2014
20 Reads
  • Source
    • "These compounds have been shown to play a major role in the immune system [20]. The ihsTLR v1.0 model comprises 781 species involved in 963 reactions [6]. Since the metabolic and signaling networks have similar time scales [5] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mathematical models of biochemical networks, such as metabolic, signaling, and gene networks, have been studied extensively and have been shown to provide accurate descriptions of various cell processes. Nevertheless, their usage is restricted by the fact that they are usually studied in isolation, without feedback from the environment in which they evolve. Integrating these models in a global framework is a promising direction in order to increase both their accuracy and predictive capacity. In this paper, we describe the integration of large-scale metabolic and signaling networks with a regulatory gene network. We focus on the response to infection in mouse macrophage cells. Our computational framework allows to virtually simulate any type of infection and to follow its effect on the cell. The model comprises 3,507 chemical species involved in 4,630 reactions evolving at the fast time scale of metabolic and signaling processes. These interact with 20 genes evolving at the slow time scale of gene expression and regulation. We develop a simulator for this model and use it to study infections with Porphyromonas gingivalis.
    01/2011; DOI:10.1109/CDC.2011.6160954
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A signalling network is a network of reactions that govern how a cell responds to its environment. A pathway is a dynamic flow of "signal" through the network (signal transduction), for example from a receptor to a transcription factor that enables expression of a gene. In this paper we introduce a method to compute all pathways in a signalling network that satisfy a simple property constraining initial, final and intermediate states. This method, concerned with signal transduction, is compared to the steady state view underlying Petri net place/transition invariants and flux balance analysis. We apply the method to the signalling network model being developed in the Pathway Logic project and identify knockout/inhibition targets and common (pathway) events. This approach also allows us to better understand and formalise the interaction between pathways in a network, for example to identifying pathway inhibition targets that limit the effect on unrelated pathways.
    Computational Methods in Systems Biology, 8th International Conference, CMSB 2010, Trento, Italy, September 29 - October 1, 2010. Proceedings; 01/2010
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The task of the DREAM4 (Dialogue for Reverse Engineering Assessments and Methods) "Predictive signaling network modeling" challenge was to develop a method that, from single-stimulus/inhibitor data, reconstructs a cause-effect network to be used to predict the protein activity level in multi-stimulus/inhibitor experimental conditions. The method presented in this paper, one of the best performing in this challenge, consists of 3 steps: 1. Boolean tables are inferred from single-stimulus/inhibitor data to classify whether a particular combination of stimulus and inhibitor is affecting the protein. 2. A cause-effect network is reconstructed starting from these tables. 3. Training data are linearly combined according to rules inferred from the reconstructed network. This method, although simple, permits one to achieve a good performance providing reasonable predictions based on a reconstructed network compatible with knowledge from the literature. It can be potentially used to predict how signaling pathways are affected by different ligands and how this response is altered by diseases.
    PLoS ONE 09/2010; 5(9). DOI:10.1371/journal.pone.0012789 · 3.23 Impact Factor
Show more